Amphotericin B

Breastfeeding
  • TRADE NAMES: Abelcet (Sigma-Tau); AmBisome (Astellas); Amphocin (Pfizer); Amphotec (Alkopharma); Fungilin; Fungizone
  • INDICATIONS: Potentially life-threatening fungal infections
  • CLASS: Antifungal
  • HALF-LIFE: initial: 15–48 hours; terminal: 15 days

Our database has 91 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
GENITOURINARY
RENAL
HEMATOLOGIC
LOCAL
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric